retatrutide phase 2 trial obesity nejm 2023 of for Triple–Hormone-Receptor Agonist Retatrutide for Obesity
Description
Pharmacologic therapy for osteoarthritisthe era of disease modification
Most successful approaches have restart threshold of 10-15 pound regain
The 12mg dose produced the highest weight loss at 24.2% over 48 weeks
The medication was also effective in improving blood sugar control and reducing the risk of cardiovascular events
Novo Nordisk press release Clayton NC $4.1 billion fill-finish facility June 2024
